Abstract
The historical basis of recent investigations on the molecular mechanism of action of vitamin D is discussed. A summary of the recent findings in regard to the 1,25-(OH)2D3 receptor has been presented, including the structural deductions, photoaffinity labeling, sites of monoclonal antibody interaction, and sites of phosphorylation. New information on the regulation of the 1, 25-(OH)2D3 receptor have been provided together with possible reasons for this regulation. Finally, analogs of 1, 25-(OH)2D3 have been describe which carry out some of the functions of 1, 25-(OH)2D3 but not others. These analogs appear to induce transcription both in vivo andin vitro of certain genes but are not able to support calcium mobilization. Their use in therapy has been suggested as has been their use in helping unravel the molecular mechanism of action of vitamin D.
Similar content being viewed by others
References
DeLuca, H. F.: The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J. 2, 224–236, 1988.
DeLuca, H. F.: The vitamin D story: A success of basic science in the treatment of disease. In: Metabolic Bone Diseases in Children (S. Castells and Finberg, L., eds.), Marcell Dekker, New York, pp. 1–41, 1990.
Pike, J. W.: Emerging concepts on the biologic role and mechanism of action of 1, 25-dihydroxyvitamin D3. Steroids 49, 3–27, 1987.
Hayashi, S., Noshiro, M. and Okuda, K.: Isolation of a cytochrome P-450 that catalyzes the 25-hydroxylation of vitamin D3 from rat liver microsomes. J. Biochem. (Tokyo) 99, 1753–1756, 1986.
Usui, E., Noshiro, M. and Okuda, K.: Molecular cloning of cDNA for vitamin D3 25-hydroxylase from rat liver mitochondria. FEBS Lett. 262, 135–138, 1990.
Burt, R. E. and Crivello, J. F.: Characterization of monoclonal antibodies specific to bovine renal vitamin D hydroxylases. Endocrinology 123, 2491–2499, 1988.
Horiuchi, N., Suda, T., Takahashi, H., Shimazawa, E. and Ogata, E.: In vivo evidence for the intermediary role of 3', 5'-cyclic AMP in parathyroid hormone-induced stimulation of 1α, 25-dihydroxyvitamin D3 synthesis in rats. Endocrinology 101, 969–974, 1977.
Barbour, G. L., Coburn, J. W., Slatopolsky, E., Norman, A. W. and Horst, R. L.: Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1, 25-dihydroxyvitamin D. New Engl. J. Med. 305, 440–443, 1981.
Fetchick, D. A., Bertolini, D. R., Sarin, P. S., Weintraub, S. T., Mundy, G.R. and Dunn, J. F.: Production of 1, 25-dihydroxyvitamin D3 by human T-cell lymphotrophic virus-I-transformed lymphocytes. J. Clin. Invest. 78, 592–595, 1986.
DeLuca, H. F. and Schnoes, H. K.: Vitamin D: Metabolism and mechanism of action. In: Annual Reports in Medicinal Chemistry (D. M. Bailey, ed.), Academic Press, New York. Vol. 19, Chapter 18, pp. 179–190, 1984.
Brommage, R. and DeLuca, H. F.: Evidence that 1, 25-dihydroxyvitamin D3 is the physiologically active metabolite of vitamin D3. Endocrine Rev. 6, 491–511, 1985.
Hodsman, A. B., Wong, E. G. C., Sherrard, D. J., Brickman, A. S., Lee, D. B.N., Singer, F. R., Norman, A. W. and Coburn, J. W.: Preliminary trials with 24, 25-dihydroxyvitamin D3 in dialysis osteomalacia. Amer. J. Med. 74, 407–409, 1983.
Link, R. and DeLuca, H. F.: The vitamin D receptor. In: The Receptors (P. M. Conn, ed.), Academicd Press, New York. Vol. II, pp. 1–35, 1985.
Barsony, J., Pike, J. W., DeLuca, H. F. and Marx, S. J.: Immunocytology with microwave-fixed fibroblasts shows 1α, 25-dihydroxycholecalciferol dependent rapid and estrogen dependent slow reorganization of vitamin D receptors. J. Cell. Biol., in press, 1990.
Nemere, I., Yoshimoto, Y. and Norman, A. W.: Calcium transport in perfused duodena from normal chicks: Enhancement within fourteen minutes of exposure to 1, 25-dihydroxyvitamin D3 Endocrinology 115, 1476–1483, 1984.
Rasmussen, H., Matsumoto, T., Fontaine, O. and Goodman, D. B. P.: Role of changes in membrane lipid structure in the action of 1, 25-dihydroxyvitamin D3 Fed. Proc. 41, 72–77, 1982.
Yamamoto, M., Kawanobe, Y., Takahashi, H., Shimazawa, E., Kimura, S. and Ogata, E.: Vitamin D deficiency and renal calcium transport in the rat. J. Clin. Invest. 74, 507–513, 1984.
Stern, P. H., Halloran, B. P., DeLuca, H. F. and Hefley, T. J.: Responsiveness of vitamin D-deficient fetal rat limb bones to parathyroid hormone in culture. Am. J. Physiol. 244, E421-E424, 1983.
Stumpf, W. E., Sar, M. and DeLuca, H. F.: Sites of action of 1, 25 (OH) xvitamin D3 identified by thaw-mount autoradiography. In: Hormonal Control of Calcium Metabolism (D. V. Cohn, Talmage, R. V. and Matthews, J. L., eds.), Excerpta Medica, Amsterdam. pp. 222–229, 1981.
Abe, E., Ishimi, Y., Takahashi, N., Akatsu, T., Ozawa, H., Yamana, H., Yoshiki, S. and Suda, T.: A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation. J. Bone Min. Res. 3, 635–647, 1988.
Horton, M. A., Lewis, D., McNulty, K., Pringle, J. A. S. and Chambers, T. J.: Monoclonal antibodies to osteoclastomas (giant cell bone tumors): Definition of osteoclast-specific cellular antigens. Cancer Res. 45, 5663–5669, 1985.
Jin, C. H., Segawa, A., Miyaura, C., Tanaka, H., Abe, E. and Suda, T.: Calcium is essential in the fusion of mouse alveolar macrophages induced by 1α, 25-dihydroxyvitamin D3. J. Cell. Physiol. 137, 110–116, 1988.
Sherwood, L. M. and Russell, J.: The role of 1, 25-(OH)2D3 in regulating parathyroid gland function. Proc. Soc. Exp. Biol. Med. 191, 233–237, 1989.
Chertow, B. S., Sivitz, W. I., Baranetsky, N. G., Clark, S. A., Waite, A. and DeLuca, H. F.: Cellular mechanisms of insulin release. The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113, 1511–1518, 1983.
Hosomi, J., Hosoi, J., Abe, E., Suda, T. and Kuroki, T.: Regulation of terminal differentiation of cultured mouse epidermal cells by 1α,25-dihydroxyvitamin D3. Endocrinology 113, 1950–1957, 1983.
Holick, M. F.: 1, 25-Dihydroxyvitamin D3 and the skin: A unique application for the treatment of psoriasis. Proc. Soc. Exp. Biol. Med. 191, 246–257, 1989.
Kwiecinski, G. G., Petrie, G. I. and DeLuca, H. F.: Vitamin D is necessary for reproductive functions of the male rat. J. Nutr. 119, 741–744, 1989.
Kwiecinski, G. G., Petrie, G. I. and DeLuca, H. F.: 1, 25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. Am. J. Physiol. 256, E483-E487, 1989.
Brumbaugh, P. F. and Haussler, M. R.: Nuclear and cytoplasmic binding components for vitamin D metabolites. Life Sci. 16, 353–362, 1975.
Kream, B. E., Reynolds, R. D., Knutson, J. C., Eisman, J. A. and DeLuca, H. F.: Intestinal cytosol binders of 1, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3. Arch. Biochem. Biophys. 176, 779–787, 1976.
Simpson, R. U., Hamstra, A., Kendrick, N. C. and DeLuca, H. F.: Purification of the receptor for 1α, 25-dihydroxyvitamin D3 from chicken intestine. Biochemistry 22, 2586–2594, 1983.
Pike, J. W., Marion, S. L., Donaldson, C. A. and Haussler, M. R.: Serum and monoclonal antibodies against the chick intestinal receptor for 1, 25-dihydroxyvitamin D3. J. Biol. Chem. 258, 1289–1296, 1983.
Dame, M. C., Pierce, E. A., Prahl, J. M., Hayes, C. E. and DeLuca, H. F.: Monoclonal antibodies to the porcine intestinal receptor for 1, 25-dihydroxyvitamin D3: Interaction with distinct receptor domains. Biochemistry 25, 4523–4534, 1986.
Dame, M. C., Pierce, E. A. and DeLuca, H. F.: Identification of the porcine intestinal 1, 25-dihydroxyvitamin D3 receptor on sodium dodecyl sulfate-polyacrylamide gels by renaturation and immunoblotting. Proc. Natl. Acad. Sci. USA 82, 7825–7829, 1985.
Mangelsdorf, D. J., Pike, J. W. and Haussler, M. R.: Avian and mammalian receptors for 1, 25-dihydroxyvitamin D3: In vitro translation to characterizesize and hormone-dependent regulation. Proc. Natl. Acad. Sci. USA 84, 354–358, 1987.
Pierce, E. A., Dame, M. C. and DeLuca, H. F.: Size and charge of the functional 1, 25-dihydroxyvitamin D receptor in porcine intestine. J. Biol. Chem. 262, 17092–17099, 1987.
Burmester, J. K., Maeda, N. and DeLuca, H. F.: Isolation and expression of rat 1, 25-dihydroxyvitamin D3 receptor cDNA. Proc. Natl. Acad. Sci. USA 85, 1005–1009, 1988.
Burmester, J. K., Wiese, R. J., Maeda, N. and DeLuca, H. F.: Structure and regulation of the rat 1, 25-dihydroxyvitamin D3 receptor. Proc. Natl. Acad.Sci. USA 85, 9499–9502, 1988.
Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J. and O'Malley, B. W.: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA 85, 3294–3298, 1988.
McDonnell, D. P., Mangelsdorf, D. J., Pike, J. W., Haussler, M. R. and O'Malley, B. W.: Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235, 1214–1217, 1987.
McDonnell, D. P., Scott, R. A., Kerner, S. A., O'Malley, B. W. and Pike, J. W.: Functional domains of the human vitamin D3 receptor egulate osteocalcin gene expressions. Mol. Endocrinol. 3, 635–637, 1989.
Brown, T. A. and DeLuca, H. F.: Photoaffinity labeling of the 1, 25-dihydroxyvitamin D3 receptor. Biochim. Biophys. Acta., in press, 1990.
Brown, T. A., Prahl, J. M. and DeLuca, H. F.: Partial amino acid sequence of porcine 1, 25-dihydroxyvitamin D3 receptor isolated by immunoaffinity chromatography. Proc. Natl. Acad. Sci. USA 85, 2454–2458, 1988.
Hughes, M. R., Malloy, P. J., Kieback, D. G., Kesterson, R. A., Pike, J. W., Feldman, D. and O'Malley, B. W.: Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242, 1702–1706, 1988.
Sone, T., Scott, R. A., Hughes, M. R., Malloy, P. J., Feldman, D., O'Malley, B. W. and Pike, J. W.: Mutant vitamin D receptors which confer hereditary resistance to 1, 25-dihydroxyvitamin D3 in humans are transcriptionally inactivein vitro. J. Biol. Chem. 264, 20230–20234, 1989.
Sone, T., McDonnell, D. P., O'Malley, B. W. and Pike, J. W.: Expression and large scale purification of recombinant human vitamin D receptor from s. cerevisiae. J. Bone Min. Res., no. 537, S208 (abstract), 1990.
Brown, T. A. and DeLuca, H. F.: Phosphorylation of the 1, 25-dihydroxyvitamin D3 receptor: A primary event in 1, 25-dihydroxyvitamin D3 action. J. Biol. Chem. 265, 10025–10029, 1990.
Pike, J. W. and Sleator, N. M.: Hormone-dependent phosphorylation of the 1,25-dihydroxyvitamin D3 receptor in mouse fibroblasts. Biochem. Biophys. Res. Commun. 131, 378–385, 1985.
Lee, Y., Inaba, M., DeLuca, H. F. and Mellon, W. S.: Immunological identification of 1, 25-dihydroxyvitamin D3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulations. J. Biol. Chem. 264, 13701–13705, 1988.
Strom, M., Sandgren, M. E., Brown, T. A. and DeLuca, H. F.: 1, 25-Dihydroxyvitamin D3 up-regulates the 1, 25-dihydroxyvitamin D3 receptorin vivo. Proc. Natl. Acad. Sci. USA 86, 9770–9773, 1989.
Costa, E. M. and Feldman, D.: Homologous up-regulation of the 1, 25 (OH)2 vitamin D3 receptor in rats. Biochem. Biophys. Res. Commun. 137, 742–747, 1986.
Sandgren, M. E. and DeLuca, H. F.: Serum calcium and vitamin D regulate 1, 25-dihydroxyvitamin D3 receptor concentration in rat kidneyin vivo. Proc. Natl. Acad. Sci. USA 87, 4312–4314, 1990.
Desplan, C., Thomasset, M. and Moukhtar, M.: Synthesis, molecular cloning, and restriction analysis of DNA complementary to vitamin D-dependent calcium-binding protein mRNA from rat duodenum. J. Biol. Chem. 258, 2762–2765, 1983.
Darwish, H. M., Krisinger, J., Strom, M. and DeLuca, H. F.: Molecular cloning of the cDNA and chromosomal gene for vitamin D-dependent calcium-bindingprotein of rat intestine. Proc. Natl. Acad. Sci. USA 84, 6108–6111 (1987).
Krisinger, J., Darwish, H., Maeda, N. and DeLuca, H. F.: Structure and nucleotide sequence of the rat intestinal vitamin D-dependent calcium binding protein gene. Proc. Natl. Acad. Sci. USA 85, 8988–8992, 1988.
Perret, C., Lomri, N., Gouhier, N., Auffray, C. and Thomasset, M.: The rat vitamin-D-dependent calcium-binding protein (9-kDa CaBP) gene. Complete nucleotide sequence and structural organization. Eur. J. Biochem. 172, 43–51, 1988.
Darwish, H., Krisinger, J., Furlow, J. D., Smith, C., Murdoch, F. E. and DeLuca, H. F.: An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus. J. Biol. Chem., in press, 1990.
Kerner, S. A., Scott, R. A. and Pike, J. W.: Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3 Proc. Natl. Acad. Sci. USA 86, 4455–4459, 1989.
Demay, M. B., Gerardi, J. M., DeLuca, H. F. and Kronenberg, H. M.: DNA sequences in the rat osteocalcin gene that bind the 1, 25-dihydroxyvitamin D3 receptor and confer responsiveness to 1, 25-dihydroxyvitamin D3 Proc. Natl. Acad. Sci. USA 87, 369–373, 1990.
Noda, M., Vogel, R. L., Craig, A. M., Prahl, J., DeLuca, H. F. and Denhardt, D. T.: Identification of a DNA sequence responsible for binding of the 1, 25-dihydroxyvitamin D3 receptor and 1, 25-dihydroxyvitamin D3 enhancementof mouse secreted phosphoprotein 1 (Spp1, osteopontin) gene expression. Proc. Natl. Acad. Sci. USA, in press, 1990.
Schule, R., Umesono, K., Mangelsdorf, D. J., Bolado, J., Pike, J. W. and Evans, R. M.: Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61, 497–504, 1990.
Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S. and Suda, T.: Differentiation of mouse myeloid leukemia cells induced by 1α, 25-dihydroxyvitamin D3 Proc. Natl. Acad. Sci. USA 78, 4990–4994, 1981.
Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y. and Suda, T.: 1α, 25-Dihydroxycholecalcifrol and a human myeloid leukaemia cell line (HL-60). The presence of a cytosol receptor and induction of differentiation. Biochem. J. 204, 713–719, 1982.
Holick, M. F., Smith, E. and Pincus, S.: Skin as the site of vitamin D synthesis and target tissue for 1, 25-dihydroxyvitamin D3: Use of calcitriol (1, 25-dihydroxyvitamin D3) for treatment of psoriasis. Arch. Dermatol. 123, 1677–1679, 1987.
Smith, E. L., Walworth, N. C. and Holick, M. F.: Effect of 1α,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J. Invest. Dermatol. 86, 709–714, 1986.
Ostrem, V. K., Lau, W. F., Lee, S. H., Perlman, K., Prahl, J., Schnoes, H. K., DeLuca, H. F. and Ikekawa, N.: Induction of monocytic differentiation of HL-60 cell by 1, 25-dihydroxyvitamin D analogs. J. Biol. Chem. 262, 14164–14171, 1987.
Abe, J., Takita, Y., Nakano, T., Miyaura, C., Suda, T. and Nishii, Y.: A synthetic analogue of vitamin D3, 22-oxa-1α, 25-dihydroxyvitamin D3, is a potent modulator ofin vivo immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124, 2645–2647, 1989.
Calverley, M. J.: Synthesis of MC903, a biologically active vitamin D metabolite analogue. Tetrahedron Lett. 43, 4609–4619, 1987.
Krisinger, J., Strom, M., Darwish, H. D., Perlman, K., Smith, C. and DeLuca, H. F.: Induction of calbindin-D 9k mRNA but not calcium transport in rat intestine by 1, 25-dihydroxyvitamin D3-24-homologs. J. Biol. Chem., in press, 1990.
Author information
Authors and Affiliations
About this article
Cite this article
DeLuca, H.F. Recent advances in the molecular mechanism of action of 1, 25-dihydroxyvitamin D3 . J Bone Miner Metab 9, 17–25 (1991). https://doi.org/10.1007/BF02377980
Issue Date:
DOI: https://doi.org/10.1007/BF02377980